Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q4 2020 Results - Earnings Call Transcript

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2020 Earnings Conference Call November 23, 2020 4:30 PM ET

Company Participants

Jennifer Viera - Senior Director, IR & Corporate Communications
Jay Luly - President, CEO & Director
Paul Mellett - SVP, Finance & Administration and CFO

Conference Call Participants

Roy Buchanan - JMP Securities
Yasmeen Rahimi - Piper Sandler
Eric Joseph - JP Morgan
Jay Olson - Oppenheimer

Operator

Good afternoon and welcome to Enanta Pharmaceuticals fiscal fourth quarter and year-end 2020, financial results call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end of the prepared remarks. Please be advised that this call is being recorded.

I would now like to turn the call over to Jennifer Viera, Senior Director, Investor Relations. Please go ahead.

Jennifer Viera

Thank you, operator, and thanks to everyone for joining us this afternoon. The news release with our fiscal fourth quarter and 2020 year-end financial results was issued this afternoon and is available on our website.

On the call today is, Dr. Jay Luly President and Chief Executive Officer; Paul Mellett, our Chief Financial Officer and other members of Enanta’s Senior Management team.

Before we begin with our formal remarks, we want to remind you that we will be making forward-looking statements, which may include our plans and expectations with respect to our research and development pipeline and financial projections, all of which involve certain assumptions and risks beyond our control that could cause our actual development and results to differ materially from those statements. A description of these risks is in our most recent Form 10-Q and other periodic reports filed with the SEC. Enanta does not undertake any obligation to update any forward-looking statements made during this call.

I'd now like to turn the call